Neena M. Patil - Nov 8, 2024 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
EVP & Chief Legal Officer
Signature
By: /s/Adam Guttmann, as attorney in fact For: Neena M Patil
Stock symbol
JAZZ
Transactions as of
Nov 8, 2024
Transactions value $
-$456,617
Form type
4
Date filed
11/13/2024, 05:44 PM
Previous filing
May 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Sale -$457K -3.7K -10.07% $123.41 33K Nov 8, 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $123.31 to $123.51. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.
F2 Includes 119 ordinary shares acquired on May 31, 2024 under a Section 423 Employee Stock Purchase Plan.